The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EBMT 2016 | ‘Off the shelf’ virus-specific T cells

Name: ‘Off the shelf’ virus-specific T cells
Uploaded: 2017-03-04T00:00:00.000Z
Duration: 1 min 14 s
Description: Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of the 'off the shelf' use of virus-specific T cell therapy. At the moment, the therapy targets 5 viruses but the aim is to include more viruses over time. Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.

Ann Leen • 4 Mar 2017

EBMT 2016

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia B-Cell Lymphoma Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Hodgkin Lymphoma Mantle Cell Lymphoma

Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of the ‘off the shelf’ use of virus-specific T cell therapy. At the moment, the therapy targets 5 viruses but the aim is to include more viruses over time.
Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.